anesthesia glp-1 guidance news #160 Breaking Perioperative News: Receptor Agonist Alert A narrative review of glucagon-like

Injectable semaglutide, oral semaglutide, tirzepatide, and emerging dual-action compounds represent different clinical approaches with varying mechanisms and onset profiles

We hold ourselves to high standards of natural purity, Potency, and Third Party Tested

If Lilly receives Priority Review designation (possible given the unmet medical need in obesity), the review timeline could compress by several months

Many patients find that the reduced appetite makes it easier to adopt healthier eating patterns, since the intense cravings and hunger that previously sabotaged their efforts are significantly diminished

1 OT2 OD026557

Jo CH, Kim S, Kim G-H (2022) Claudins in kidney health and disease